Suppr超能文献

相似文献

1
Characterizing aggressiveness and predicting future progression of CF lung disease.
J Cyst Fibros. 2009 Jun;8 Suppl 1(0 1):S15-9. doi: 10.1016/S1569-1993(09)60006-0.
2
Predicting disease progression in cystic fibrosis.
Expert Rev Respir Med. 2018 Nov;12(11):905-917. doi: 10.1080/17476348.2018.1519400. Epub 2018 Sep 13.
4
Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function.
J Cyst Fibros. 2019 Jan;18(1):71-77. doi: 10.1016/j.jcf.2018.09.008. Epub 2018 Oct 31.
6
A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.
Eur Radiol. 2018 Jan;28(1):74-84. doi: 10.1007/s00330-017-4870-4. Epub 2017 Jun 29.
7
Determination of mortality from cystic fibrosis.
Pneumologia. 2010 Jul-Sep;59(3):170-3.
8
Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry.
J Cyst Fibros. 2021 Jan;20(1):86-90. doi: 10.1016/j.jcf.2020.04.008. Epub 2020 May 5.
9
A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.
Ann Epidemiol. 2013 Dec;23(12):771-7. doi: 10.1016/j.annepidem.2013.08.009. Epub 2013 Oct 5.
10
Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Eur Respir J. 2014 Jan;43(1):125-33. doi: 10.1183/09031936.00166412. Epub 2013 Apr 18.

引用本文的文献

1
Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis.
mSystems. 2025 Jun 17;10(6):e0019625. doi: 10.1128/msystems.00196-25. Epub 2025 May 28.
2
A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis.
Pulm Ther. 2024 Dec;10(4):483-494. doi: 10.1007/s41030-024-00269-9. Epub 2024 Sep 12.
6
, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?
Microorganisms. 2021 Jun 11;9(6):1275. doi: 10.3390/microorganisms9061275.
9
Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids.
Pediatr Res. 2021 Jul;90(1):99-108. doi: 10.1038/s41390-021-01419-4. Epub 2021 Mar 2.

本文引用的文献

1
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
J Pediatr. 2008 Dec;153(6):746-51. doi: 10.1016/j.jpeds.2008.07.010. Epub 2008 Aug 30.
2
Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.
Am J Respir Crit Care Med. 2007 Dec 1;176(11):1084-9. doi: 10.1164/rccm.200702-181OC. Epub 2007 Sep 13.
3
High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
J Pediatr. 2007 Sep;151(3):249-54. doi: 10.1016/j.jpeds.2007.04.009. Epub 2007 Jun 26.
4
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
J Pediatr. 2007 Aug;151(2):134-9, 139.e1. doi: 10.1016/j.jpeds.2007.03.006. Epub 2007 Jun 22.
5
Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.
Am J Respir Crit Care Med. 2006 Oct 1;174(7):780-6. doi: 10.1164/rccm.200512-1919OC. Epub 2006 Jul 20.
7
Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis.
J Pediatr. 2003 Jun;142(6):624-30. doi: 10.1067/mpd.2003.152.
8
Factors influencing outcomes in cystic fibrosis: a center-based analysis.
Chest. 2003 Jan;123(1):20-7. doi: 10.1378/chest.123.1.20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验